Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma

BACKGROUND: Approximately 50% of patients with uveal melanoma (UM) will develop metastatic disease, usually involving the liver. The outcome of metastatic UM (mUM) is generally poor and no standard therapy has been established. Additionally, clinicians lack a validated prognostic tool to evaluate th...

Descripción completa

Detalles Bibliográficos
Autores principales: Valpione, Sara, Moser, Justin C., Parrozzani, Raffaele, Bazzi, Marco, Mansfield, Aaron S., Mocellin, Simone, Pigozzo, Jacopo, Midena, Edoardo, Markovic, Svetomir N., Aliberti, Camillo, Campana, Luca G., Chiarion-Sileni, Vanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363319/
https://www.ncbi.nlm.nih.gov/pubmed/25780931
http://dx.doi.org/10.1371/journal.pone.0120181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363319/
https://www.ncbi.nlm.nih.gov/pubmed/25780931
http://dx.doi.org/10.1371/journal.pone.0120181

Ejemplares similares